The putative carboxyl-terminal processing protease (CtpA) of Brucella suis 1330 is a member of a novel family of endoproteases involved in the maturation of proteins destined for the cell envelope. The B. suis CtpA protein shared up to 77% homology with CtpA proteins of other bacteria. A CtpA-deficient Brucella strain (1330⌬ctpA), generated by allelic exchange, produced smaller colonies on enriched agar plates and exhibited a 50% decrease in growth rate in enriched liquid medium and no growth in salt-free enriched medium compared to the wild-type strain 1330 or the ctpA-complemented strain 1330⌬ctpA[pBBctpA]. Electron microscopy revealed that in contrast to the native coccobacillus shape of wild-type strain 1330, strain 1330⌬ctpA possessed a spherical shape, an increased cell diameter, and cell membranes partially dissociated from the cell envelope. In the J774 mouse macrophage cell line, 24 h after infection, the CFU of the strain 1330⌬ctpA declined by approximately 3 log 10 CFU relative to wild-type strain 1330. Nine weeks after intraperitoneal inoculation of BALB/c mice, strain 1330⌬ctpA had cleared from spleens but strain 1330 was still present. These observations suggest that the CtpA activity is necessary for the intracellular survival of B. suis. Relative to the saline-injected mice, strain 1330⌬ctpA-vaccinated mice exhibited 4 to 5 log 10 CFU of protection against challenge with virulent B. abortus strain 2308 or B. suis strain 1330 but no protection against B. melitensis strain 16 M. This is the first report correlating a CtpA deficiency with cell morphology and attenuation of B. suis.
Animal brucellosis is a disease affecting various domestic and wildlife species, resulting from infection with bacteria belonging to the genus Brucella (11) . Brucellosis is a zoonotic disease, and human infection is normally acquired either through consumption of contaminated dairy and meat products or by contact with infected animal secretions (1) . Brucella species are facultative intracellular pathogens that can enter the host via mucosal surfaces and are able to survive inside macrophages. The primary strategy for survival in macrophages appears to be inhibition of phagosome-lysosome fusion (6, 7, 31) . This is followed by localization and survival within replicative phagosomal compartments associated with the rough endoplasmic reticulum and has been demonstrated in placental trophoblasts and other nonprofessional phagocytes (3, 24, 36) . Molecular characterization of this survival process is important because it would provide additional guidance for the development of measures for prevention and control of Brucella and perhaps other intracellular pathogens.
It is well known that many proteins destined for extracytoplasmic locations are initially synthesized as precursor forms and processed into mature forms by proteolytic cleavage to remove short peptide sequences, near either the amino terminus or the carboxyl terminus. The endoproteases responsible for cleaving of amino-terminal peptides are called amino-terminal processing proteases (13) . A relatively new class of endoproteases with carboxyl-terminal processing activities has been described for various bacteria and organellar systems, including cyanobacteria, Escherichia coli, and chloroplasts (23, 35, 42, 46) . These carboxyl-terminal proteases (Ctps) from cyanobacteria, E. coli, and green plants share significant sequence similarities (21, 33) . However, none of them exhibits sequence homology with other protease classes with well-defined mechanisms of action. Ctps are serine proteases that utilize a Ser/Lys catalytic dyad instead of the well-known Ser/ His/Asp catalytic triad (34) .
The bacterial cell shape is defined by peptidoglycan, a rigid layer vital for bacterial survival, as it is the anchor for both inner and outer cell membranes in gram-negative bacteria. The building blocks for the synthesis of peptidoglycan are created in the cytoplasm, transported across the cytoplasmic membrane, and polymerized on the outer surface of the inner membrane (20, 30) . Complete assembly of peptidoglycan requires a glycosyltransferase that polymerizes the glycan strands and a transpeptidase activity that cross-links the strands via their peptide side chains. These activities are performed by a group of enzymes called penicillin-binding proteins (PBP) (50) . The fact that ␤-lactam antibiotics like penicillin irreversibly bind to these enzymes led to naming them PBPs (53) . Through their influence on the synthesis of the cell wall peptidoglycan layer, the PBPs strongly influence the size, shape, and time of division of bacteria (50) .
The enzymes of the PBP-1 family are believed to determine the size and the growth of the bacterial cell. These PBPs act as peptidoglycan synthetases because they provide both the glycosyltransferase and transpeptidase activities that are required to polymerize peptidoglycan (37, 54) . The enzymes of the PBP-2 and PBP-3 families are believed to determine the extent of elongation and division of rod-shaped cells. These enzymes form peptide cross-links between the glycan chains of peptidoglycan (20, 30, 37) .
The carboxyl-terminal protease Prc is responsible for cleavage of C-terminal 11-amino-acid residues of precursor PBP-3 of E. coli (19) . The E. coli mutant JE7304, developed by deleting the prc gene encoding Prc protein, was defective in the C-terminal processing of PBP-3 (18) . This mutant showed thermosensitive growth on a salt-free L-agar plate, suggesting that the prc gene was involved in some essential cellular process, which may be related to the cell division function of PBP-3 (19) . The prc function thus seemed to be involved in maintaining cell wall integrity and protection from thermal and osmotic stresses. Loss of Prc function also resulted in leakage of periplasmic proteins, including RNase I and alkaline phosphatase (19) . The leaky phenotype of the prc mutant has been attributed to the impairment of the structural integrity of the outer membrane, which could lead to sensitivity to osmotic stress. A Prc-deficient E. coli strain exhibited a filamentous cell morphology, confirming the role of Prc on processing of PBP-3 (19) .
The protein encoded by the ctpA gene of Brucella suis shared considerable homology with the Ctps of other bacteria. Therefore, we hypothesized that the protein encoded by this gene is a C-terminal protease and could play a significant role in determining the cell morphology and the intracellular persistence of B. suis through its possible influence on cell envelope integrity. In this communication, we report that a B. suis strain defective in ctpA gene exhibits salt-sensitive growth, spherical cell morphology, and reduced persistence in mice and a mouse macrophage cell line.
MATERIALS AND METHODS
Bacterial strains, plasmids, and reagents. Brucella abortus strain 2308, Brucella melitensis strain 16 M, and B. suis strains 1330 and VTRS1 were obtained from our culture collection. E. coli strain Top10 (Invitrogen Life Technologies, Carlsbad, Calif.) was used for producing plasmid constructs. E. coli Prc mutant strain JE7929 was kindly provided by H. Hara, Saitama University, Urawa City, Japan. E. coli cells were grown in Luria-Bertani (LB) broth or on LB agar (Difco Laboratories, Sparks, Md.). Brucellae were grown in LB broth with or without sodium chloride at 30, 37, or 42°C to determine whether growth was osmosensitive and/or thermosensitive. For all other assays, brucellae were grown either in Trypticase soy broth (TSB) or on Trypticase soy agar (TSA) plates (Difco) at 37°C in the presence of 5% CO 2 as previously described (44) . The plasmids used in this study are listed in Table 1 . Bacteria containing plasmids were grown in the presence of ampicillin or kanamycin at a 100-g/ml concentration ( Table 1) .
All experiments with live brucellae were performed in a Biosafety Level 3 facility at the Infectious Disease Unit of the Virginia-Maryland Regional College of Veterinary Medicine per Centers for Disease Control and Prevention-approved standard operating procedures.
Recombinant DNA methods. Genomic DNA was isolated from B. suis strain 1330 by use of a QIAGEN blood and tissue DNA kit (QIAGEN Inc., Valencia, Calif.). Plasmid DNA was isolated using plasmid Mini-or Midiprep purification kits (QIAGEN). Restriction digests, Klenow reactions, and ligations of DNA were performed as described elsewhere (41) . Restriction enzymes, Klenow fragment, and T4 DNA ligase enzyme were purchased from Promega Corporation (Madison, Wis.). Ligated plasmid DNA was transferred to E. coli Top10 cells by heat shock transformation per the guidelines of the manufacturer (Invitrogen). Purified plasmid DNA was electroporated into B. suis with a BTX ECM-600 electroporator (BTX, San Diego, Calif.), as described previously (28) .
DNA and protein sequence analyses. The nucleotide sequence of the ctpA gene was analyzed with DNASTAR software (DNASTAR, Inc., Madison, Wis.). The presence of any signal sequence of the B. suis CtpA protein was predicted by using the SignalP 3.0 server of the Technical University of Denmark (http:// www.cbs.dtu.dk/) (9) . The destination of the CtpA protein upon translation and processing was predicted using the Subloc v1.0 server of the Institute of Bioinformatics of the Tsinghua University (http://www.bioinfo.tsinghua.edu.cn/). Homology of the B. suis CtpA to proteins of the EMBL/GenBank/DDBJ databases was analyzed using the BLAST software (2) at the National Center for Biotechnology Information (Bethesda, MD).
Mutation of the B. suis ctpA gene by allelic exchange. A 1,408-bp region including a major portion of the ctpA gene was amplified via PCR using the genomic DNA of B. suis. A primer pair consisting of a forward primer (5Ј GGGGTACCGTGGTGGACTGA 3Ј) and a reverse primer (5Ј GGCTGCAGT CCCGCGTTTTTGTCTT 3Ј) (Ransom Hill Bioscience, Inc., Ramona, Calif.) was designed based on the nucleotide sequence (GenBank accession no. NC_004310); a restriction site was engineered into each primer (KpnI in the forward primer and PstI in the reverse primer; shown in boldface characters in the primer sequences). PCR amplification was performed in an Omni Gene thermocycler (Hybaid, Franklin, Mass.) at 95°C for 5 min, followed by 35 cycles (40), which confers kanamycin resistance (Kan r ) to B. suis. The resulting suicide vector was designated pGEMctpAK. The E. coli Top10 cells carrying the recombinant plasmid were picked from TSA plates containing kanamycin (100 g/ml).
One microgram of pGEMctpAK was used to electroporate B. suis strain 1330; several colonies of strain 1330 were obtained from a TSA plate containing kanamycin (100 g/ml). These colonies were streaked on TSA plates containing ampicillin (100 g/ml) to determine whether a single-or double-crossover event had occurred. Three of the colonies did not grow on ampicillin-containing plates, suggesting that a double-crossover event had occurred. PCR with the primers used for amplifying the ctpA gene (as described above) confirmed that a doublecrossover event had taken place in all three transformants. One of these strains was chosen for further analyses and designated 1330⌬ctpA.
Complementation of ctpA gene activity in mutant 1330⌬ctpA. The 1.4-kb DNA fragment containing the B. suis ctpA gene was isolated by SacI and XbaI digestion of plasmid pCRctpA and was cloned into same sites of broad-host-range vector pBBR4MCS (25) . The resulting plasmid was designated pBBctpA. One microgram of pBBctpA was used to electroporate B. suis strain 1330⌬ctpA; several colonies of strain 1330⌬ctpA were picked from a TSA plate containing ampicillin (100 g/ml). Six of the colonies were tested for growth on TSA plates, in LB broth, or in salt-free LB broth. On TSA plates, these colonies appeared equal in size to that of the wild-type strain 1330, and in LB or salt-free LB broth they grew similarly to strain 1330. One of these colonies was chosen for further analyses and designated 1330⌬ctpA [pBBctpA] .
Complementation of prc gene activity in Prc-deficient E. coli. One microgram of pBBctpA was used to electroporate the Prc mutant E. coli strain JE7929; several colonies of strain JE7929 were picked from a TSA plate containing ampicillin (100 g/ml). Ten of the colonies were tested for growth in salt-free LB media (details to follow).
Growth rates of B. suis strains in regular or salt-free medium at different temperatures. Salt-free LB medium was prepared by mixing bactotryptone and yeast extract in water per the manufacturer's instruction (Difco) but omitting sodium chloride. Single colonies of strains 1330, 1330⌬ctpA, and 1330⌬ctpA[pBBctpA] were grown at 37°C for 24 h to stationary phase in 10 ml of TSB. The cells were harvested in two equal pellets by centrifugation. One pellet was resuspended in 1 ml of LB broth and used to inoculate 25 ml of LB broth in a Klett side-arm flask to 12 to 16 Klett units. The other pellet was resuspended in salt-free LB medium and used to inoculate 25 ml of salt-free LB broth in a Klett flask to 8 to 16 Klett units. Cultures were grown at 30, 37, or 42°C at 180 rpm; Klett readings were recorded every two h in a Klett-Summerson colorimeter (New York, NY).
Acid precipitation and denaturing gel electrophoresis of secreted proteins. Strains 1330, 1330⌬ctpA, and 1330⌬ctpA[pBBctpA] were grown in 25 ml LB broth to stationary phase (to 339, 179, and 288 Klett units, respectively). The cultures were centrifuged at 2,000 ϫ g for 15 min, and the cell-free culture medium was collected. Trichloroacetic acid was added to the medium at 5% of the final volume and incubated at 4°C overnight. The acidified medium was centrifuged at 10,000 ϫ g for 15 min to collect the protein precipitate. The insoluble material was resuspended in Laemmli sample buffer (Sigma Chemical Co., St. Louis, Mo.), boiled for 20 min, and electrophoresed on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels according to standard procedures (26) . Gels containing the separated proteins were either stained with Coomassie brilliant blue G (Sigma Chemical Co.) or used for Western blot analysis.
Western blotting. Western blotting was performed as previously described (49a). Briefly, proteins separated by SDS-PAGE were transferred to a nitrocellulose membrane by using a Trans-blot semidry system (Bio-Rad Laboratories, Hercules, CA). The membranes were blocked with a solution of 1.5% nonfat milk powder plus 1.5% bovine serum albumin. For analysis of trichloroacetic acid-insoluble proteins, the membranes were incubated with goat anti-heat-killed B. abortus polyclonal serum (Goat-48) for 24 h and subsequently developed with rabbit anti-goat immunoglobulin G (whole molecule) conjugated with horseradish peroxidase (Sigma Chemical Co.).
Electron microscopy. Strains 1330 and 1330⌬ctpA were grown in 25 ml LB broth to stationary phase. The cultures were centrifuged at 2,000 ϫ g for 15 min to harvest the cells. One half of the pellet from each strain was used to inoculate 100 ml LB broth, whereas the other half was used to inoculate 100 ml salt-free LB broth. The cultures were incubated overnight at 37°C with vigorous shaking. The cells were harvested by centrifugation at 2,000 ϫ g for 15 min and fixed overnight at 4°C in formaldehyde-paraformaldehyde in cacodylate buffer (8) . The samples were then processed for thin-section electron microscopy as described by Banai et al. (8) . The sections were mounted on copper grids, stained with uranyl acetate and lead citrate, and examined with a JOEL 100 CX-II transmission electron microscope (Zeiss 10C; Carl Zeiss Inc., New York, NY) at ϫ10,000 magnification.
Preparation of B. suis inoculum stocks. TSA plates were inoculated with single colonies of B. suis strains. After 4 days of incubation at 37°C with 5% CO 2 , the cells were harvested from plates, washed with phosphate-buffered saline (PBS), resuspended in 20% glycerol, and frozen at Ϫ80°C. The number of viable cells was determined after dilutions of the cell suspensions were plated on TSA.
Persistence of recombinant B. suis strains in macrophages. The mouse macrophage-like cell line J774 was obtained from the American Type Culture Collection (Manassas, VA). The J774 macrophage cells were seeded at a density of 5 ϫ 10 5 /ml in Dulbecco's modified essential medium (Sigma-Aldrich) into 24-well tissue culture dishes and cultured at 37°C with 5% CO 2 until confluent. The tissue culture medium was removed, 200 l (10 8 cells) of the bacterial suspension in PBS was added, and the cells were incubated at 37°C for 4 h. The suspension above the cell monolayer was removed, and the cells were washed three times with PBS. One milliliter of Dulbecco's modified essential medium containing 25 g of gentamicin was added, and the cells were incubated for 48 h at 37°C. At various time points (0, 24, and 48 h of incubation), the growth medium was removed, the cells were washed with PBS, and 500 l of 0.25% sodium deoxy- (51) . Mice were sacrificed at 6 weeks after inoculation, and the Brucella CFU count per spleen was determined as described previously (44) . Briefly, spleens were collected and homogenized in TSB. Serial dilutions of each spleen's homogenates were plated on TSA plates. The number of CFU that appeared on plates was determined after 4 days of incubation at 37°C.
To determine the clearance of strains in different time intervals, groups of 25 mice were each injected with 4.0 to 4.1 log 10 CFU of B. suis strains 1330 or 1330⌬ctpA. Groups of five mice injected with each strain were sacrificed at 1, 3, 5, 7, and 9 weeks after inoculation, and the Brucella CFU count per spleen was determined as described above.
Protective efficacy of B. suis mutant 1330⌬ctpA. Six-week-old female BALB/c mice (The Jackson Laboratory, Bar Harbor, Maine) were allowed 1 week of acclimatization. Groups of seven mice each were intraperitoneally injected with PBS, strain 1330⌬ctpA, or strain VTRS1. Two doses of strain 1330⌬ctpA or VTRS1, i.e., a high dose, which was similar to the dose used in clearance study, and a low dose, which was 1 log 10 CFU lower than the above-described dose, were used in vaccination. Eight weeks postinoculation, mice were intraperitoneally challenged with 4.7 log 10 CFU of wild-type, virulent B. suis strain 1330. Two weeks postchallenge, mice were sacrificed and the Brucella CFU count per spleen was determined as described above. In a separate trial, 10 BALB/c mice were intraperitoneally injected with PBS, and another 12 were inoculated with 5.3 log 10 CFU of strain 1330⌬ctpA. Six weeks postinoculation, five mice injected with PBS and six mice inoculated with strain 1330⌬ctpA were intraperitoneally challenged with 3.5 log 10 CFU of wild-type, virulent B. abortus strain 2308. The other five mice injected with PBS and the six mice inoculated with strain 1330⌬ctpA were challenged with 5.1 log 10 CFU of wild-type, virulent B. melitensis strain 16 M. Two weeks postchallenge, mice were sacrificed and the Brucella CFU count per spleen was determined as described above.
Data analyses. The mean and the standard deviation values from the clearance and protection studies were calculated using the Microsoft Excel 2001 program (Microsoft Corporation). The Student t test was performed in the analysis of CFU data in the macrophage study and the protection study involving strain 2308 and 16 M challenge. The CFU data from the splenic clearance study and the protection study involving strain 1330 challenge were analyzed by performing analysis of variance, and the mean CFU counts among treatments were compared using the least-significance pair-wise comparison procedure (49) .
RESULTS
Nucleotide and protein sequence of ctpA. The coding region of the ctpA gene is 1,274 bp long and is located between bp 1768433 and 1769707 on chromosome I of the B. suis genome (accession number NP_698817). The predicted molecular mass of CtpA was 45.2 kDa. Analysis of the putative CtpA protein sequence predicted that it does not contain a signal sequence (signal peptide probability: 0.006). The predicted subcellular localization of CtpA was periplasmic space (reliability index ϭ 2; expected accuracy ϭ 85%).
At the amino acid level, the ctpA gene shared 99% identity with the tail-specific protease of B. melitensis. Additionally, it showed up to 77% identity with carboxyl-terminal proteases of a number of bacterial species, including Bartonella quintana, Mesorhizobium loti, Sinorhizobium meliloti, and Agrobacterium tumefaciens, and up to 61% identity with periplasmic proteases of other bacteria, including Rhodopseudomonas palustris, Rhodobacter sphaeroides, and Magnetospirillum magnetotacticum (Table 2) .
Genomic characterization of CtpA-deficient B. suis strain. A PCR assay with the primer pair used to amplify the ctpA gene (see Materials and Methods) produced a predicted 1.4-kb-size amplicon not only from the parent type B. suis but also from B. abortus, B. canis, and B. melitensis (data not shown). These primers yielded an approximately 2.2-kb product from strain 1330⌬ctpA (Fig. 1 ), indicating that due to a double-crossover event, a 471-bp region was deleted from the ctpA gene, and the 1.3-kb Kan r fragment was inserted at the deletion site of the strain 1330 genome.
Growth rates of recombinant B. suis strains. After 3 days of growth on TSA plates, colonies of strain 1330⌬ctpA appeared approximately one-third to one-half the size of the colonies of strain 1330 (data not shown). In LB broth, the growth of the strain 1330⌬ctpA was slower (approximately 9 h doubling time) than that of strain 1330 (approximately 6 h doubling time) (Fig.  2, top) . In salt-free LB broth, the CtpA-deficient strain exhibited zero growth, whereas strain 1330 grew with approximately 8.5 h doubling time (Fig. 2, bottom) . The growth rates of strain (Fig. 2) . However, the salt-sensitive growth of Prcdeficient E. coli strain JE7929 could not be restored when the B. suis ctpA gene was introduced into this strain. Leakage of periplasmic proteins. To find out any possible leakage of proteins, the proteins from culture supernatants were precipitated with acid and subjected to immunoblotting. No significant differences were observed between strain 1330 and strain 1330⌬ctpA, as judged by staining of precipitated proteins separated by SDS-PAGE. No visible immunoreactive proteins were seen on Western immunoblots using hyper-immune anti-Brucella goat serum (data not shown), indicating that disruption of the ctpA gene does not cause gross leakage of proteins from Brucella cells.
Cell morphology. When examined by electron microscopy, the wild-type strain 1330 grown in LB medium with or without salt displayed the native coccobacillus shape of Brucella cells (Fig. 3A and B) . In contrast, the CtpA-deficient strain 1330⌬ctpA grown in LB broth displayed a spherical shape and a slightly increased diameter. Additionally, the outer membrane of these cells partially dissociated from the rest of the cell envelope (Fig. 3C) . When strain 1330⌬ctpA was introduced into salt-free growth broth, the cell size increased substantially and the cell membrane was significantly dissociated; the cells appeared to be almost spheroplast-like (Fig. 3D) .
Persistence of B. suis strains in J774 macrophages. The survival of B. suis strains in J774 mouse macrophage cells was measured ( Table 3) . The results reflect a 3.09 log 10 decline of the CtpA-deficient strain compared with the parent type strain 1330 by 24 h but eventual recovery of the CtpA-deficient strain by 48 h.
Survival in mice of the B. suis strains. Survival in BALB/c mice of the CtpA-deficient strain was compared with that of the wild-type strain 1330 and the rough B. suis strain VTRS1 (51) ( Table 4 ). The virulent parent type strain 1330 persisted in mice for more than 6 weeks with only 0.83 log 10 CFU decline, whereas strain 1330⌬ctpA declined by 3.21 log 10 CFU and strain VTRS1 declined by 2.92 log 10 CFU during the same period. In a separate trial, the splenic clearance of strains was estimated at 2-week intervals (Fig. 4) . One week after inoculation, the average splenic recovery of the strain 1330⌬ctpA remained at 4.0 log 10 CFU, while recovery was 2.1 log 10 CFU higher for the parent strain. At 5 and 7 weeks postinoculation, strain 1330⌬ctpA had been cleared from some mice, causing relatively larger CFU standard deviation values. Nine weeks postinoculation, strain 1330⌬ctpA cleared from spleens of all the mice but the parent strain 1330 was still present.
Protective efficacy of attenuated B. suis strains. Mice immunized with 4.34 and 5.34 log 10 CFU of the strain 1330⌬ctpA exhibited 3.20 and 3.75 log 10 units of protection, respectively (Table 5) , against a challenge of wild-type B. suis strain 1330. All colonies harvested from spleens of mice injected with this strain were sensitive to kanamycin (Kan s ), indicating that they all were from the challenge strain 1330 (Kan s ), as opposed to the vaccine strain 1330⌬ctpA (Kan r ). In comparison, strain VTRS1 provided no protection when mice were vaccinated with 4.20 log 10 CFU but provided 1.26 log 10 CFU protection when vaccinated with 5.20 log 10 CFU dose. Nearly one-quarter of the colonies harvested from mice immunized with 5.20 log 10 CFU of strain VTRS1 were resistant to kanamycin, indicating that the VTRS1 dose had not been completely cleared from the spleens in 10 weeks. In a separate trial, it was shown that immunization with the CtpA-deficient strain 1330⌬ctpA induced 4.71 and 0.37 log 10 CFU units of protection against challenge with virulent B. abortus parent type strain 2308 and virulent B. melitensis parent type strain 16 M, respectively (Table 6 ).
DISCUSSION
The deduced protein encoded by the ctpA gene was predicted to localize in the periplasmic space of the cell. This protein sequence showed substantial homology with the carboxyl-terminal proteases and periplasmic proteases of other related bacterial species. It further showed 31% homology at the amino acid level to the Prc protein identified as the carboxyl-terminal processing protease for PBP-3 of E. coli (19, 46) . Cell fractionation studies had indicated that Prc is localized in the periplasmic space of E. coli (19) . On the basis of the greater homology between bacterial carboxyl-terminal proteases and periplasmic proteases, we believe that these two protein groups are the same, even though they had been named differently.
Compared to the parent strain, the CtpA-deficient strain produced relatively smaller colonies on TSA plates and exhibited slower growth in liquid growth media, suggesting that the function of CtpA is important for the growth of B. suis. The inability of the CtpA-deficient strain to grow in salt-free media suggests that CtpA function is involved either directly or indirectly in protection from osmotic stresses.
Brucella suis CtpA shared considerable homology with the E. coli Prc protein, and the CtpA-deficient B. suis and the Prcdeficient E. coli strains (19) displayed similar salt-sensitive growth levels. The Prc protein processes PBP proteins and regulates the cell morphology of E. coli (19) . Accordingly, we tested whether CtpA is involved in determining the cell morphology of B. suis. Electron microscopy data revealed that the CtpA-deficient B. suis strain possessed a spherical cell shape with a slightly increased cell diameter. Previous reports have shown that the PBP-2-deficient E. coli strains lack the cell elongation pathway and grow as spherical cells, because only septal synthesis is active in these strains (16) . Additionally, in E. coli, when PBP-2 is inhibited by amdinocillin (which inhibits sidewall elongation by PBP-2 homologs), the diameter of newly formed poles increases by up to 26% (14, 16) . Similarly, the diameter of the peptidoglycan stalk of Caulobacter crescentus increases when its PBP-2 homolog is inactivated (45) . A PBP-2-deficient strain of Erwinia amylovora displayed a large spherical phenotype, whereas its parent type counterpart displayed a rod-shaped phenotype (29) . These reports suggest that PBP-2 enzyme helps to regulate cellular diameter at the time of division. Based on these observations it can be hypothesized that the CtpA protein is involved in processing of PBP-2 enzyme in B. suis, and disruption of ctpA resulted in a spherical cell shape with an increased cell diameter. Since the PBPs are involved in cell wall peptidoglycan synthesis, the loss of cell wall integrity and dissociation of cell membranes of the CtpAdeficient B. suis strain can be related to the possible interruption of peptidoglycan synthesis due to inhibition of PBP activity as a result of a lack of CtpA activity. In E. coli, PBP-3 redirects most peptidoglycan synthesis to the invaginating septum (15, 52) and thereby induces cell septation (47, 48) . Inhibition of PBP-3 activity blocks formation of septa and thereby blocks cell division. In E. coli, the antibiotic mezlocillin at low concentrations binds preferentially to PBP-3 and as a result induces filamentous phenotype of cells (12) . As described above, in E. coli, PBP-3 is processed into a mature form by the protein Prc, and the Prc-deficient mutants of E. coli failed to process PBP-3 and produced a filamentous phenotype (19) . Because of CtpA protein's homology to Prc, and due to similarities in salt sensitivity between Prc-deficient E. coli and CtpA-deficient B. suis, we anticipated seeing a filamentous cell shape in the CtpA-deficient B. suis strain. However, CtpA-deficient B. suis did not exhibit such a morphology; therefore, we conclude that CtpA does not have an impact on PBP-3. Interestingly, the B. suis genome does not carry a gene encoding a protein homologous to PBP-3 of other bacteria but does contain three PBP-1 homologs, one PBP-2 homolog, and three PBP-6 homologs (accession numbers NC_004310 and NC_004311.2).
It has been shown that cell diameter is reduced by about 20% and that the average cell length increases in a PBP-1 mutant of B. subtilis (27, 38, 39) . Since the CtpA-deficient B. suis strain exhibited a spherical cell shape, it is apparent that CtpA in Brucella cells may not influence PBP-1 activity. However, further work is required to confirm CtpA's definite involvement in regulating the activities of PBP-2 and/or other PBPs. Work is under way in our laboratory to mutate each gene encoding PBP enzymes of B. suis. If the CtpA-deficient strain exhibits morphology similar to that seen with any of the generated PBP-deficient strains, we can confirm that CtpA influences the function of that particular PBP(s).
Further phenotypical and functional differences were seen between the CtpA-deficient B. suis strain and the Prc-deficient E. coli mutant (19) . The Prc-deficient E. coli grew in salt-free media at low temperatures (30°C) but not at high temperatures (42°C), exhibiting temperature dependency. In contrast, the CtpA-deficient B. suis strain did not grow at any temperature when it was introduced into salt-free media, indicating that CtpA in Brucella cells does not have a temperature dependency. Hara et al. (19) reported that disruption of Prc expression of E. coli resulted in leakage of proteins from cells. However, the mutation in the ctpA gene of B. suis did not cause leakage of proteins in substantial quantities, as seen by staining or Western blotting; however, these detection methods may not be sensitive enough to trace any small-scale leakages. When the ctpA gene was introduced into Prc-deficient E. coli by transformation, its growth in salt-free media could not be restored. This may be due to significant functional differences between the Prc of E. coli and the CtpA of Brucella strains; i.e., Prc is involved in processing of PBP-3 whereas CtpA is apparently involved in processing of PBP-2.
Colonies produced by the CtpA-deficient strain complemented with the ctpA gene were similar in size to those produced by the parent type strain 1330. Additionally, the complemented strain grew at a rate similar to that of the parent type strain in LB or salt-free LB media. These results indicate that complementation of the ctpA gene has restored the CtpA activity of mutant 1330⌬ctpA, and the phenotype of strain 1330⌬ctpA is the result of a specific mutation in ctpA and not a polar effect.
When grown in J774 macrophages, the persistence of the CtpA-deficient strain compared to that of wild-type strain 1330 declined significantly after 24 h of incubation, indicating that CtpA is important for survival, in particular against early killing by macrophages. Apparently, due to the loss of cell wall integrity, the CtpA-deficient cells were unable to avoid phagosome-lysosome fusion and thereby were subjected to early killing. The clearance studies in mice revealed that 1 week after inoculation, a significantly smaller number of strain 1330⌬ctpA bacteria were recovered compared to those of the wild-type strain 1330. Nine weeks after inoculation, the CtpA-deficient strain was cleared completely from mouse spleens, whereas the parent type strain was still present. Overall, the slow growth of this mutant strain in enriched media, and its low persistence in mice and greater sensitivity to killing by mouse macrophages, suggests that it has a diminished capacity for extracellular and intracellular growth. This is similar to the observed attenuation exhibited by PBP-2-deficient E. amylovora in mice (29) . E. coli mutants lacking both PBP-1a and -1b were nonviable, confirming that one or the other of these enzymes is essential for persistence of the bacterium (22, 54) . Thus, if the CtpA of B. suis truly influences the processing of PBPs and peptidoglycan integrity, the reduced persistence of CtpA-deficient B. suis is not totally unexpected.
The CtpA-deficient strain induced excellent protection against challenge with virulent parent type B. suis strain 1330, and the level of protection slightly increased with an increased vaccine dose. The protection induced by the CtpA-deficient strain was much greater than that induced by rough B. suis strain VTRS1 (Table 5 ) and can likely be attributed to induction of specific antibody responses to O-side chain. This is consistent with published literature suggesting that the specific humoral and cellular responses to O-side chain are important in producing good protection (4, 5, 10) . The inability of the CtpA-deficient strain to protect against challenge with B. melitensis strain 16 M, i.e., cross-species protection, has been noted previously with other Brucella vaccine strains (43) . Currently, brucellosis in animal species is diagnosed by detecting the serum antibodies to O-side chain (32) . As a vaccine candidate, a major drawback associated with the CtpA-deficient strain is that its smooth phenotype may lead to the production of O-side chain antibodies that may confound serodiagnosis. Alternatively, if a diagnosis assay could be developed to detect the serum antibodies to CtpA, the CtpA-deficient strain would have potential as a brucellosis vaccine candidate.
In summary, the protein encoded by the B. suis ctpA gene is involved in protecting cells from osmotic pressure and determining growth rate, colony size, cell morphology, and intracellular survival during acute as well as chronic phases of infection. The CtpA-deficient B. suis strain induces significant protection in BALB/c mice against challenge with virulent brucellae.
